[1] 左东波,倪玲.前臂骨折骨缺损应用带皮质骨髂骨块植骨治疗的效果研究[J].东方食疗与保健,2017,15(9):341.
[2] 周训银,李研,吴殿源,等.血管化自体骨移植重建下颌骨的研究[J]. 解放军医学杂志,2003, 28(7):630-632
[3] 罗飞,许建中.结构性异体骨移植材料力学性能的影响因素[J].中华创伤杂志,2002,18(7):444-446.
[4] MUELLER TL, WIRTH AJ, VAN LENTHE GH, et al. Mechanical stability in a human radius fracture treated with a novel tissue-engineered bone substitute: a non-invasive, longitudinal assessment using high-resolution pQCT in combination with finite element analysis. J Tissue Eng Regen Med.2011;5(5): 415-420.
[5] TAYLOR GI, MILLER GD, HAM FJ. The free vascularized bone graft. A clinical extension of microvascular techniques. Plast Reconstr Surg. 1975 ;55 (5):533- 544 .
[6] 李远辉,杨运发,胡汉生,等.带血管腓骨移植修复四肢大段骨缺损:可有效促进骨愈合[J].中国组织工程研究,2015,19(11):1641-1646.
[7] GUGALA Z, LINDSEY RW, GOGOLEWSKI S. New approaches in the treatment of critical-size segmental defects in long bones. Macromol Symp.2007;253:147-161.
[8] VAN HONWELINGEN AP, MCKEE MD. Treatnrent of os-teopenichumeral shaft nonunion with compression plating,humeral cortical allograft struts,and bone grafting.J Orthop Trauma. 2005;19(1): 36-42.
[9] 张翼,张岩,李甲振,等.同种异体骨移植重建四肢恶性骨肿瘤切除后骨缺损[J].中国矫形外科杂志,2019,27(3):225-229.
[10] 刘天礽,曾元临,钟招明,等.同种异体骨移植的研究进展[J].中华创伤杂志, 2003,19(8):507-508.
[11] 钟甫华,张春,郭峭峰,等.Ilizarov 骨搬移技术治疗下肢创伤后严重复杂感染长段骨缺损[J].浙江医学,2019,41(5):449-452.
[12] 蔡善保,孟祥晖.大段骨缺损治疗的研究进展[J].中华创伤杂志, 2015, 31(4):376-379.
[13] 杜永伟,刘真,莫建文,等.Ilizarov骨短缩-延长术与游离腓骨段移植技术治疗大段胫骨骨缺损的效果及对Puno功能评分的影响[J]. 广东医学,2019, 40(13):2331-2334.
[14] 冯震,张猛,吴薇娜.“手风琴”技术治疗骨折不愈合模型兔[J]. 中国组织工程研究,2018,22(32): 5175-5179
[15] 于福铎. Ilizarov技术在治疗下肢创伤后感染性骨缺损的研究[J].中国医药科学,2019,9(16):218-220.
[16] MASQUELET AC, FITOUSSI F, BEGUE T, et al. Reconstruction of the Long bones by the induced membrane and spongy auto graft. Ann Chiv Plast Esthel. 2000;45(3): 346-353.
[17] 陈鹏,甄相周,凌建生,等. Masquelet 技术治疗骨缺损的临床效果分析[J].中国骨与关节损伤杂志,2019,5(34):545-547.
[18] 余清文,赵东升,郑晓勇,等.Masquelet技术治疗骨折后骨缺损疗效的荟萃分析[J].中国矫形外科杂志,2018,26(24): 2254-2259.
[19] MAUFFREY C, CHAUS GW, BUTLER N, et al. MR-compatible antibiotic interlocked nail fabrication for the management of long bone infections:first case report of a new technique. Patient Saf Surg. 2014; 8(1):14-21.
[20] MASQUELET A C, FITOUSSI F, BEGUE T, et al. Reconstruction des os longs par membrane induite et autogreffe spongieuse. Ann Chir Plast Esthet. 2000;45(3): 346-353.
[21] 杨聪林林,陈元标,马绍华,等. Masquelet技术治疗感染性骨缺损的疗效分析[J].临床医药文献杂志,2019,6(27):65-66.
[22] 金嘉诚. Masquelet 技术在骨缺损修复中的应用进展[J].中医正骨,2019, 6(31):32-34.
[23] 徐建平,李妹霞,左杨斌,等.硫酸钙介导的诱导膜技术与常规诱导膜技术治疗胫骨创伤后大段骨缺损的临床疗效对比[J].生物骨科材料与临床研究, 2019,16 (4):10-13.
[24] BAKHSHALIAN N, JALAYER T, SHAHOON H, et al. Osteopromotive property of allogenic demineralized dentin matrix: a pilot study. J West Soc Periodontol Periodontal Abstr. 2013;61(2):35-38.
[25] 杨维东.口腔领面骨替代材料与骨组织工程[J].实用口腔医学杂志, 1999, 15(6):469-471.
[26] 王俊钢,李聪聪,毛广显,等.骨生物材料复合骨髓间充质干细胞异位成骨修复肋骨大段缺损[J].中国组织工程研究,2017, 21(2): 182-186.
[27] NICODEMOU A, DANISOVIC L. Mesenchymal stromal/stem cell separation methods:concise review. Cell Tissue Bank. 2017; 18(4) : 443-460.
[28] EVANS MJ, KAUFMAN MH. Establishment in culture of pluripotential cells from mouse embryos. Nature.1981;292 (5819):154-156.
[29] TAKAHASHI K, YAMANAKA S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
[30] KFOURY Y, SCADDEN DT. Mesenchymal cell contributions to the stem cell niche. Cell Stem Cell. 2015;16(3):239-253.
[31] OSUGI M, KATAGIRI W, YOSHIMI R, et al. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A. 2012;18(13-14):1479-1489.
[32] 束佳鑫,周建业,刘泽文,等.β-TCP联合骨髓基质细胞比较单独应用β-TCP治疗骨缺损体内实验的Meta分析[J].西北民族大学学报,2019,45(6): 45-50.
[33] BANFI A, MURAGLIA A, DOZIN B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells:Implications for their use in cell therapy. Exp Hematol. 2001; 28 (6) :707-715.
[34] HELDER MN, KNIPPENBERG M, KLEIN-NULEND J, et al. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng. 2007;13 (8):1799-1808.
[35] MOON KM, PARK YH, LEE JS, et al. The effect of secretory factors of adipose-derived stem cells on human keratinocytes. Int J Mol Sci. 2012;13(1) :1239-1257.
[36] SIEGEL KR, CLEVENGER TN, CLEGG DO, et al. Adipose stem cells incorporated in fibrin clot modulate expression of growth factors. Arthroscopy. 2018; 34(2):581-591.
[37] PETERS MC, POLVERINI PJ, MOONEY DJ. Engineering vascular networks in porous polymer matrices.J Biomed Mater Res. 2002; 60(4):668-678.
[38] BISHOP A T, PELZER M. Vascularized bone allotransplantation: current state and implications for future recon structive surgery. Orthop Clin North Am. 2007;38(1): 109-122.
[39] LI D, SUN H, JIANG L, et al. Enhanced biocompatibility of PLGA nanofibers with gelatin / nano-hydroxyapatite bone biomimetics incorporation. ACS Appl Mater Interfaces. 2014; 6(12): 9402-9410.
[40] HE X, FAN X, FENG W, et al. Incorporation of microfibrillated cellulose into collagen-hydroxyapatite scaffold for bone tissue engineering. Int J Biol Macromol. 2018;115:385-392.
[41] TARAFDER S, BOSE S. Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo osteogenesis.ACS Appl Mater Interfaces.2014;6(13): 9955-9965.
[42] 腾强,丁焕文.3D打印间孔结构人工支架复合自体骨的异位成骨研究[D]. 广州:广州中医药大学,2016.
[43] GIANNOUDIS PV, FAOUR O, GOFF T, et al. Masquelet technique for the treatment of bone defects: tips-tricks and future directions. Injury. 2011;42(6): 591-598.
[44] ZHAO M, ZHOU J, LI X, et al. Repair of bone defect with vascularized tissue engineered bone graft seeded with mesenchymal stem cells in rabbits.Microsurgery.2011;31 (2):130-137.
[45] 曹波,马创,魏琴,等.血小板衍生因子促进内皮细胞血管化的实验研究[J].临床和实验医学杂志,2017,16(24):2393-2397.
[46] ASAHARA T, MUROHARA T, SULLIVAN A, et al. Isolation of putative progenitor endothelial cells for angiogenesis . Science. 1997; 275 (5302): 964-967.
[47] USAMI K, MIZUNO H, OKADA K, et al.Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.J Biomed Mater Res A. 2019; 90(3):730-741.
[48] OZBOLAT IT, YU Y. Bioprinting toward organ fabrication: challenges and future trends.IEEE Trans Biomed Eng.2013; 60(3):691-699.
[49] YU X, WU H, LI J, et al. Antibiotic cement-coated locking plate as a temporary internal fixator for femoral osteomyelitis defects. Int Orthop. 2017;41(9):1851-1857.
|